Work

P057 PROSPER: A phase 3 study of enzalutamide in non-metastatic (M0) castration-resistant prostate cancer (CRPC) patients

Year: 2014

Type: conference-abstract

Source: European Urology Supplements

DOI: 10.1016/s1569-9056(14)61280-x

Authors: A. Heidenreich, C. Sternberg, K. Fizazi, F. Saad, N.D. Shore, M. Hirmand, F. Perabo, Z. Khondker, K. Modelska, M. Hussain

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2407643387

Cites:

Cited by: 1

Related to: 10